OHLCX Market Research
Delayed

ILMN

ILMN stands for Illumina, Inc., a company specializing in genetic sequencing and genomics.

−7.66 (−3.82%) Nov 20, 2026 16:56 ET Delayed
Open
—
High
—
Low
—
Prev close
200.66
Volume
—
Avg vol 10
2M

Today · Market closed · opens Mon 9:30 AM

Price

ILMN chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 193.00

Strong sellNeutralStrong buy
Sell
score −0.33 · 18 signalling
2Buy
8Neutral
8Sell

Leaning sell. 8 of 18 signals point down against 2 up, carried by momentum and trend. Volatility leans buy. Volume is mostly neutral. Stochastic, Williams %R and CCI sit in oversold territory. Trend strength is strong (ADX 27).

How to read this →

Trend

MACD 12, 26, 9
Below signal line and zero
MACD −15.64 · Signal −13.09 · Hist −2.55
Sell
ADX 14
Strong trend, −DI ahead
ADX 27.10 · +DI 20.10 · −DI 30.38
Sell
Parabolic SAR 0.02, 0.2
Above price, 38.66 over the close
231.66
Sell
Ichimoku 9, 26, 52
Price below cloud, conversion below base
Conv 209.48 · Base 242.73 · A 268.18 · B 248.00
Sell

Momentum

RSI 14
Below midpoint, not oversold
33.64
Neutral
Stoch 14, 3
Oversold, %K still below %D
%K 3.31 · %D 11.46
Neutral
Stoch RSI 14, 14, 3, 3
Mid-range, %K still above %D
%K 45.00 · %D 38.89
Neutral
Williams %R 14
Oversold zone, falling
−96.69
Neutral
CCI 14
Below −100, still falling
−130.35
Neutral
MFI 14
Below midpoint, not oversold
41.04
Neutral
ROC 12
Price down 14.81% over 12 bars
−14.81%
Sell
AO 5, 35
Below zero, rising
−44.56
Neutral
TRIX 18
Below zero
−0.506
Sell
KST 10/15/20/30, 3
Below its signal line
KST −215.13 · Signal −205.70
Sell

Volatility

Bollinger 20, 2
Lower half, %b 0.21
Up 287.21 · Mid 227.36 · Low 167.52
Neutral
Keltner 20, 10, 1.5
Below the lower channel
Up 241.49 · Mid 221.49 · Low 201.49
Buy

Volume

VWAP 345-bar
Close 18.6% above VWAP
162.72
Buy
Force Index 1
Negative, sellers in control
−15.0M
Sell
ATR
13.78
7.14% of close
A/D Line
41.3M
cumulative
OBV
−8.4M
cumulative
Volume Profile
119.62 – 135.43
POC · bull 104.8M · bear 81.9M · 56 / 44
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

-28.43%

Change in value over the past month.

3 month return

-13.62%

Change in value over the last three months.

Max drawdown

34.35%

Largest fall from a peak to the low that followed.

Standard deviation

51.20%

How far daily returns stray from their average, annualised.

Sharpe ratio

1.05

Return above the risk-free rate per unit of volatility.

Calmar ratio

1.57

Annualised return against the maximum drawdown.

About

ILMN summary

Loading summary…

Questions

ILMN, answered

How does Illumina’s technology impact research?

Illumina’s technology accelerates research in genetics, enabling breakthroughs in understanding diseases and treatments.

What are Illumina’s key partnerships?

Illumina partners with various organizations, including research institutions and healthcare providers, to advance genomic research.

When was Illumina founded?

Illumina was founded in 1998 and has since become a leader in DNA sequencing technology.

How does Illumina contribute to personalized medicine?

Illumina’s technologies enable researchers and clinicians to tailor treatments based on individual genetic profiles.

What industries does Illumina serve?

Illumina serves the healthcare, research, and pharmaceutical industries through its genomic solutions.

What is Illumina’s primary product?

Illumina’s primary products are DNA sequencing machines and reagents used in genomic analysis.

What is Illumina’s market position?

Illumina is a market leader in the genomics space, widely recognized for its innovation and extensive product range.

How does Illumina support healthcare advancements?

Illumina supports healthcare advancements by providing tools that facilitate genomic research and diagnostics.

What advancements has Illumina made in sequencing technology?

Illumina has developed high-throughput sequencing technologies that significantly reduce costs and increase accuracy.

How can investors learn more about Illumina?

Investors can visit Illumina’s official website to access investor relations information and financial reports.

News

ILMN in the news

Unlock Your ILMN Trading Now

Empower your trading with ohlcx.com. Our comprehensive platform delivers precise analysis and strategic insights for ILMN, designed to improve your trading outcomes. Boost your investment success with us and unlock new opportunities with our advanced system!

Experience Excellence Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.